Ritter Daniher Financial Advisory’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AIM
FWIA
DLA
ETC
Ritter Daniher Financial Advisory's BMY Position: Q2 2026 in Review
Ritter Daniher Financial Advisory held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 6,513 shares worth $375K. The position accounts for 0.06% of the portfolio, ranked #122.
Ritter Daniher Financial Advisory first reported a position in BMY in Q4 2020 and has held it in 23 quarters since. The position peaked at $470K in Q2 2022. 878 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Ritter Daniher Financial Advisory held 6,513 shares of Bristol-Myers Squibb worth $375K as of Q2 2026.
- Ritter Daniher Financial Advisory left its Bristol-Myers Squibb share count unchanged in Q2 2026.
- Bristol-Myers Squibb made up 0.06% of Ritter Daniher Financial Advisory's portfolio in Q2 2026, its #122 holding.
- Ritter Daniher Financial Advisory first reported a position in Bristol-Myers Squibb in Q4 2020 and has held it in 23 quarters since.
- Ritter Daniher Financial Advisory's Bristol-Myers Squibb position peaked at $470K in Q2 2022.
- 878 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Ritter Daniher Financial Advisory's 13F filing for Q2 2026, filed 14 Jul 2026.